Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Classement en actions #42764
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$150.00
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Poniard Pharmaceuticals, Inc. (PARD)

Catégorie

Le prix PARD avec la capitalisation boursière de B
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Capitalisation boursière de Poniard Pharmaceuticals, Inc.(PARD)
Capitalisation boursière: $150.00
En August 2026, Poniard Pharmaceuticals, Inc. a une capitalisation boursière de $150.00. Cela fait de Poniard Pharmaceuticals, Inc. la 42764th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Poniard Pharmaceuticals, Inc. du 1988 au 2026
PARD par rapport au top 5 des plus populaires stocks
Prix pour PARD L’actif B La capitalisation boursière de B Résultats
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,617,422 $150.00
$5.426T +3,617,422,497,233.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,950,690 $150.00
$4.426T +2,950,689,820,300.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,772,487 $150.00
$4.159T +2,772,487,368,067.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,441,719 $150.00
$3.663T +2,441,718,854,566.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,927,923 $150.00
$2.892T +1,927,923,257,620.67%